AgomAb Therapeutics NV

AGMB · Biological Products, (No Disgnostic Substances)

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

  • Epstein David R: Form 4

    Insider disclosure · Filed · Report period 21 Oct 2026

  • Form 4

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • AGMB · 00860C102 - American Depositary Shares, each representing one common share, no nominal value per share
Company details and SEC sources

CIK 0002020932 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
AGMB on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
Business address
Posthoflei 1/6, Antwerpen, 2600
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 2 profile fields available
Incorporated in
Belgium
Fiscal year end
31 December
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .